Device Trial Radar · NCT03527784
Prestoma-Trial for Parastomal Hernia Prevention
Last checked: Nov 19, 2026Latest source record: Nov 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
14
Actual
Start
May 3, 2018
Primary completion
Oct 29, 2018
Study completion Oct 29, 2018
Sponsor
- Lead sponsor
- University of OuluAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 17, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prestoma Trial is designed to compare the safety and efficiency of three different meshes and techniques to prevent parastomal hernia after laparoscopic or robotic-assisted abdominoperineal resection for rectal adenocarcinoma.
Conditions
- Rectal Adenocarcinoma
Interventions
Parietene MacroDevice
Parietene Macro is used on retromuscular sublay position. The bowel is brought through opening in the middle of the mesh.
Parietex ParastomalDevice
Parietex Parastomal is used on intraperitoneal onlay position by modified Sugarbaker technique to prevent parastomal hernia.
Dynamesh IPSTDevice
Dynamesh IPST is used on intraperitoneal onlay position to prevent parastomal hernia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of parastomal herniaTime frame: 1 year
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Helsinki University Hospital
Helsinki, Finland
Jyväskylä Central Hospital
Jyväskylä, Finland
Oulu University Hospital
Oulu, Finland
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.